Notification That Quarterly Report Will Be Submitted Late (nt 10-q)
May 15 2019 - 5:27PM
Edgar (US Regulatory)
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
FORM 12b-25
Commission File Number
000-53500
NOTIFICATION OF LATE FILING
(Check One):
¨
Form 10-K
¨
Form 11-K
¨
Form 20-F
x
Form 10-Q
¨
Form N-SAR
For Period Ended: March 31, 2019
|
¨
Transition Report on Form 10-K
|
|
¨
Transition Report on Form 10-Q
|
|
¨
Transition Report on Form 20-F
|
|
¨
Transition Report on Form N-SAR
|
|
¨
Transition Report on Form 11-K
|
|
|
For the Transition Period Ended:
Read Attached Instruction Sheet Before
Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that
the Commission has verified any information contained herein.
If the notification relates to a portion of the filing checked
above, identify the Item(s) to which the notification relates:
Part I-Registrant Information
|
Full Name of Registrant
|
|
Creative Medical Technology Holdings, Inc.
|
|
|
|
|
|
Former Name if Applicable
|
|
|
|
|
|
|
|
Address of principal executive office
|
|
3008 W Lupine Ave
|
|
|
|
|
|
City, State and Zip Code
|
|
Phoenix, Arizona 85029
|
Part II-Rules 12b-25 (b) and (c)
If the subject report could not be filed
without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed.
(Check box if appropriate)
x
|
a.
|
The reasons described in reasonable detail in Part III
of this form could not be eliminated without unreasonable effort or expense;
|
|
b.
|
The subject annual report, semi-annual report, transition report on Form 10-K, 20-F, 11-K or Form N-SAR, or portion thereof
will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition
report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and
|
|
c.
|
The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
|
Part III-Narrative
State below in reasonable detail the reasons
why the form 10-K, 11-K, 20-F, 10-Q or N-SAR, or the transition report or portion thereof could not be filed within the prescribed
time period. (Attach extra sheets of needed.)
The Company has been unable to complete
the review process with the auditor.
Part IV-Other Information
|
1.
|
Name and telephone number of person to contact in regard to this notification
|
Timothy Warbington
|
(602)
|
680-7439
|
(Name)
|
(Area Code)
|
(Telephone No.)
|
|
2.
|
Have all other periodic reports required under section 13 or 15(d) of the Securities Exchange Act of 1934 or section 30 of
the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to
file such report(s) been filed? If the answer is no, identify report(s).
|
x
Yes
¨
No
|
3.
|
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year
will be reflected by the earnings statements to be included in the subject report or portion thereof?
|
¨
Yes
x
No
If so, attach an explanation of the anticipated change,
both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results
cannot be made.
Creative
Medical Technology Holdings, Inc.
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the
undersigned thereunto duly authorized.
Date: May 15, 2019
|
By:
|
/s/
Donald Dickerson
|
|
|
Donald Dickerson, Chief Financial Officer
|